Question 1

Which countries lead S100 Proteins and Annexins research?

Accepted Answer

By volume, China and the United States publish the most (1.4k and 904 works in 2022-now).

Question 2

Which institutions lead S100 Proteins and Annexins research?

Accepted Answer

By volume in 2022-now, Capital Medical University publishes the most S100 Proteins and Annexins research, followed by Harvard University and Shanghai Jiao Tong University.

Question 3

Who are the leading researchers in S100 Proteins and Annexins?

Accepted Answer

The most-cited researchers publishing on S100 Proteins and Annexins include Guido Kroemer, John J.V. McMurray and Hermann Brenner.

Question 4

Where is S100 Proteins and Annexins research done?

Accepted Answer

The largest centres of S100 Proteins and Annexins research in 2022-now are Beijing (China), Shanghai (China), Guangzhou (China) and Moscow (Russia). Among places with at least 20 works in it, it is an unusually large share of all research in Gothenburg and Bethesda.

Question 5

Where is the best place to study S100 Proteins and Annexins?

Accepted Answer

Among universities, judged by research, Harvard University, University of Gothenburg and Capital Medical University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

Question 6

Is S100 Proteins and Annexins research growing?

Accepted Answer

Output in 2022-2025 was 10% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are S100 Proteins and Annexins.

Question 7

What are the most cited papers in S100 Proteins and Annexins?

Accepted Answer

The most cited paper in S100 Proteins and Annexins is "Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment." (Harold P. Adams, Birgitte H. Bendixen, L. Jaap Kappelle et al., 1993), with 12,468 citations. Next come "Interobserver agreement for the assessment of handicap in stroke patients." (6,579) and "Astrocyte–endothelial interactions at the blood–brain barrier" (5,649).